Skip to main content

Main navigation

  • Schizophrenia Foundations
  • Symptomatology
  • Patient Burden
  • Caregiver Perspectives
  • Psychopharmacology

Main navigation

  • Schizophrenia Foundations
  • Symptomatology
  • Patient Burden
  • Caregiver Perspectives
  • Psychopharmacology

Can Peripherally Restricted Anticholinergics Like Trospium Reduce Risks?

September 17, 2025

HMP ยท Can Peripherally Restricted Anticholinergics Like Trospium Reduce Risks?

Welcome to Schizophrenia Knowledge Base

This website is intended for healthcare professionals in the United States.

Yes, I am a US healthcare professional
No, I am not a US healthcare professional

Greg Mattingly, MD examines safer alternatives and their limitations.

Related Content

Can Anticholinergic Medications Make Movement Disorders Worse?
Patient Concerns About Deprescribing: How to Address Them
Understanding the Cholinergic System
Patient Case Studies: Successful Deprescription of Anticholinergics
How to Taper Anticholinergic Medications Safely
How Do Emerging Muscarinic Agonists Like KarXT Affect Anticholinergic Use?
Treatment Options and Managing Side Effects in Schizophrenia
© 2026 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use Cookie Policy